Anti-Folate Receptor Alpha-Directed Antibody Therapies Restrict the Growth of Triple-negative Breast Cancer. (2018)
Attributed to:
Preclinical efficacy of an antibody of the IgE class against a melanoma-associated antigen
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/1078-0432.ccr-18-0652
PubMed Identifier: 30068707
Publication URI: http://europepmc.org/abstract/MED/30068707
Type: Journal Article/Review
Volume: 24
Parent Publication: Clinical cancer research : an official journal of the American Association for Cancer Research
Issue: 20
ISSN: 1078-0432